Paradigm Biocapital Advisors LP has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a sale of 1870499 shares of Olema Pharmaceuticals, Inc. ($OLMA) on August 01, 2024.
Activity breakdown: 1 open-market purchase and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Paradigm Biocapital Advisors LP | TenPercentOwner | S | Common Stock, par value $0.0001 per share | 1870499 | $14.92 | 5,503,600.0000 | 45,247,098 | 25.37% | 4.13% |
| Aug. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Paradigm Biocapital Advisors LP | TenPercentOwner | S | Common Stock, par value $0.0001 per share | 529501 | $14.92 | 5,503,600.0000 | 45,247,098 | 8.78% | 1.17% |
| Dec. 6, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Paradigm Biocapital Advisors LP | TenPercentOwner | P | Common Stock, par value $0.0001 per share | 100000 | $11.60 | 7,903,600.0000 | 0 | 1.28% | 0.00% |